Catalyst Wire Dossier Catalyst Wire Dossier

Glaukos Trabecular Micro-Bypass System iS3 Infinite

· Glaukos Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glaukos Trabecular Micro-Bypass System iS3 Infinite, covering 2024-08-15 to 2024-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor [NA]

See pricing